From: MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer
Parameters | n | miR-501 level | p value | |
---|---|---|---|---|
Low (n = 332) | High (n = 206) | |||
Age | ||||
 < 55 | 97 | 61 | 36 | 0.807 |
 ≥ 55 | 437 | 269 | 168 | |
Peritoneal washing | ||||
 Negative | 344 | 215 | 129 | 0.681 |
 Positive | 57 | 34 | 23 | |
Tumor status | ||||
 With tumor | 77 | 52 | 25 | 0.688 |
 Tumor free | 422 | 275 | 147 | |
Lymph nodes (pelvic) | ||||
 Negative | 339 | 213 | 126 | 0.018* |
 Positive | 73 | 35 | 38 | |
Lymph nodes (aortic) | ||||
 Negative | 263 | 160 | 103 | 0.119 |
 Positive | 36 | 17 | 19 | |
Stage | ||||
 I | 338 | 202 | 136 | 0.200 |
 II–IV | 199 | 130 | 69 | |
Recurrence | ||||
 No | 415 | 279 | 136 | 0.842 |
 Yes | 76 | 46 | 30 |